Exploring Potential Gender-Based Disparities in Referral for Transplant, Activation on the Waitlist and Kidney Transplantation in a Canadian Cohort.
探討加拿大一個群體中,基於性別的潛在差異在移植轉診、等候名單啟動及腎臟移植中的情況。
Kidney Int Rep 2024-07-31
Efficacy and Safety of Lumasiran in Patients With Primary Hyperoxaluria Type 1: Results from a Phase III Clinical Trial.
Lumasiran 在一型原發性高草酸尿患者中的療效與安全性:來自第三期臨床試驗的結果。
Kidney Int Rep 2024-07-31
Living with Atypical Hemolytic Uremic Syndrome in the Netherlands: Patient and Family Perspective.
在荷蘭與非典型溶血性尿毒症綜合症共存:病患及家庭的觀點。
Kidney Int Rep 2024-07-31
Corrigendum to "WCN24-1051 CLINICAL PROFILE, DIAGNOSIS, THERAPEUTIC INTERVENTION AND COMPLICATIONS IN RENAL BIOPSY IN CKD POPULATION - SINGLE CENTER 20 YEARS' EXPERIENCE" [<i>Kidney International Reports</i> Volume 9, Issue 4, Supplement, April 2024, Page S86].
對於「WCN24-1051 CLINICAL PROFILE, DIAGNOSIS, THERAPEUTIC INTERVENTION AND COMPLICATIONS IN RENAL BIOPSY IN CKD POPULATION - SINGLE CENTER 20 YEARS' EXPERIENCE」的更正 [<i>Kidney International Reports</i> 第9卷,第4期,補充,2024年4月,第S86頁]。
Kidney Int Rep 2024-07-31
Derangement in Nicotinamide Adenine Dinucleotide Metabolism is Observed During Acute Kidney Injury Among Male Agricultural Workers at Risk for Mesoamerican Nephropathy.
在面臨中美洲腎病風險的男性農業工人中,急性腎損傷期間觀察到煙酰胺腺嘌呤二核苷酸代謝的紊亂。
Kidney Int Rep 2024-07-31
Corrigendum to "WCN24-1897 MONOCLONAL GAMMOPATHY OF RENAL SIGNIFICANCE AND MONOCLONAL IMMUNOGLOBULIN RELATED KIDNEY DAMAGE IN B-CELL MALIGNANCIES: THE REAL CLINICAL PRACTICE" [<i>Kidney International Reports</i> Volume 9, Issue 4, Supplement, April 2024, Page S624-S625].
對於「WCN24-1897 MONOCLONAL GAMMOPATHY OF RENAL SIGNIFICANCE AND MONOCLONAL IMMUNOGLOBULIN RELATED KIDNEY DAMAGE IN B-CELL MALIGNANCIES: THE REAL CLINICAL PRACTICE」的更正 [<i>Kidney International Reports</i> 第9卷,第4期,補充,2024年4月,頁S624-S625]。
Kidney Int Rep 2024-07-31
<i>Ex vivo</i> C5b-9 Deposition Test to Monitor Complement Activity in Clinical and Subclinical Atypical Hemolytic Uremic Syndrome and in Transplantation-Associated Thrombotic Microangiopathy.
<i>Ex vivo</i> C5b-9 沉積測試以監測臨床及亞臨床型非典型溶血性尿毒症綜合症及移植相關血栓性微血管病中的補體活性。
Kidney Int Rep 2024-07-31